Assessment of Medico-economic Relevance of Care of Polypathological Patients by a Reinforced Home Nursing Care Services (SSIAD) Device

NCT03992040 | Completed DMC

• 1 other identifier: 2019-A01188-49
• Study Type: observational
• Target: 677
• Locations: 1 country
• Sites: 1

Brief Summary

The main purpose is to study, in comparison to classic Home Nursing Care Services (SSIAD), the effect of reinforced Home Nursing Care Services (SSIAD) on the occurrence of hospitalizations

Conditions

Polypathological Patient Having Obtained a Place in Home Nursing Care Services SSIAD by Medical Prescription

Keywords

Regional Public Health authorities (ARS) score; Reinforced Home Nursing Care Services (SSIADR)

Outcome Measures

Primary Outcomes (1)

• Assessment of hospitalization frequency for patients with Reinforced SSIAD compared to similar patients in classic SSIAD.

  Assess the hospitalization frequency for patients with an enhanced SSIAD placement compared to similar patients in conventional SSIAD.

  12 months

Secondary Outcomes (8)

• Assessment of commorbidity risk according Charlson score

  12 months

• Assessment of the degree of patient dependence according "Index of Independence in Activities of Daily Living" KATZ scale

  12 months

• Assessment of patient's level of dependence through an appreciation of instrumental activities of daily living according Lawton scale

  12 months

• Assessment of teh degree of autonomy according AGGIR score

  12 months

• Assessment of quality of life according "Nottingham health profile" scale

  12 months

Study Arms (2)

Reinforced SSIAD (SSIADR arm )

Reinforced Home Nursing Care Services: Patients with a score between 11 and 21 on the regional public health authorities (ARS) score. This arm will benefit from better coordination and delivery of care, which can reduce hospitalizations and visits to emergency departments

Classic SSIAD (Control arm)

Classic Home Nursing Care Services. For this arm, no direct benefit is expected since taking care, even for the heaviest patients, corresponds to current practice.

Eligibility Criteria

• Age: 60 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The target population for this study is elderly, polypathological patients who have been prescribed SSIAD. Patients eligible to participate in Reinforced SSIAD experiment are those who meet inclusion and non-inclusion criteria listed below. Patient selection will be done in the SSIAD themselves.

You may qualify if:

• Age ≥ 60 years old
• Having obtained a place in SSIAD by medical prescription
• Able to understand and respond to study questionnaires and evaluations with or without the Assistance of a third party
• Resident in territories of activities of the SSIAD participating in assessment
• With social coverage
• Having expressed non-oppostion to his participation in study and documented in his medical file
• Only for patients in " einforced SSIAD ": patient with a so-called "reinforced" bed financed by " Regional Public Health authorities " (ARS) of Ile-de-France, and with a score between 11 and 21 on the ARS score

You may not qualify if:

• Age \< 60 years old
• Expressing his opposition to participate in the study
• Not resident in the territory of activity of SSIAD
• Requires only technical care and management in the act
• Unable to understand and respond to study questionnaires and evaluations, even with third party assistance

Sponsors & Collaborators

• Gérond'if: lead

Study Sites (1)

SSIAD SAPA, 139 Boulevard Saint-Denis

Courbevoie, Île-de-France Region, 92400, France

Location

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 18, 2019
• First Posted: June 19, 2019
• Study Start: July 25, 2019
• Primary Completion: June 30, 2022
• Study Completion: June 30, 2023
• Last Updated: April 26, 2024

Record last verified: 2024-04

Locations

FR (1)